Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Perle Bioscience Inc.
DescriptionProton pump inhibitor (PPI) for generation of new insulin producing cells in combination with an immune tolerance agent for insulin independence
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today